This special series marks Microsoft’s 50th anniversary by looking at what’s next for a company that reshaped the technology landscape. From a newsstand in Harvard Square to a storefront in ...
Elraglusib is a Class-Leading GSK-3ß Inhibitor with a Novel, Multimodal Mechanism of Action in Multiple Refractory Cancer Trials Orphan Drug Designation in Soft Tissue Sarcomas Expands Company's ...
Fort Worth, Texas, clinical-stage biopharmaceutical company Actuate said elraglusib has shown a favorable safety profile and antitumor activity across several solid tumors, including melanoma, Ewing ...
Leading GSK-3β Inhibitor with a Novel, Multimodal Mechanism of Action in Multiple Refractory Cancer TrialsOrphan Drug Designation in Soft Tissue Sarcomas Expands Company’s Potential to Address Cancers ...
I'm sure the discussion is going to be fascinating. I'm told that, Kevin, this is -- this maybe the first time ever at an investor conference, a Chief Technology Officer of the world's, I think still ...
Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval. Actuate Therapeutics is a biopharmaceutical company. It focuses on the ...
Actuate is a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers, including pancreatic cancer and Ewing sarcoma.
If you’re looking to switch your business from an LLC to an S corporation, the first thing to understand is that an S corporation is not a separate entity. An S corporation is where you make an ...